Comparative safety and study of Shadguna Makaradhwaja prepared from thin foils of gold and residue with Guduchi Ghana (aqueous extract of Tinospora cordifolia Miers.) in management of Madhumeha (type 2 diabetes): A double-blind, randomized, clinical trial

Author:

Charde Vaibhav A.1,Kaur Harmeet B.2,Patel Kishore P.3,Patgiri B. J.4,Prajapati P. K.4

Affiliation:

1. Department of Ayurveda Pharmacy, Central Ayurveda Research Institute-CCRAS, Jhansi, Uttar Pradesh, India

2. Departmant of Rasa Shastra and Bhaishajya Kalpana, Desh Bhagat University, Fatehgarh Sahib, Punjab, India

3. Central Ayurveda Research Institute-CCRAS, New Delhi, India

4. Department of RSBK, IPGT and RA, Jamnagar, Gujarat, India

Abstract

Abstract Background: Diabetes turns out to be an intense worldwide public health problem. Makaradhwaja is in practice for the treatment of Madhumeha (diabetes mellitus) due to its Pramehaghna (antidiabetic) and Rasayana (immunomodulatory and rejuvenating) properties with the number of preclinical and clinical trials in diabetes. The present study was carried out to compare the efficacy of Shadguna Makaradhwaja prepared from (Varkha) thin foils of gold (SM-V) and Shadguna Makaradhwaja prepared from Apakwa Talastha Swarna Bhasma (residue of gold remained at the bottom of glass bottle during Kupipakwa) (SM-R) with Guduchi Ghana (GG) (aqueous extract of Tinospora cordifolia Miers) in type 2 diabetes. Materials and methods: In this prospective, randomized, double-blind clinical trial, 82 patients of type 2 diabetes were treated with SM-V with GG (250 mg) and SM-R with GG (250 mg) twice daily before food with honey for 28 days. The assessment of changes observed in hemogram, blood glucose, lipid profile, hepatic, renal profile, and clinical symptoms was carried out. Results: After 28 days of medication, fasting blood glucose level decreased significantly in SM-R, whereas postprandial blood glucose level significantly decreased in SM-V treated group. A significant improvement in subjective parameters and reduction in blood and urine sugar was noted with baseline. Hemogram and hepatic and renal function profiles (safety parameters) in both groups were not significantly different from the baseline. No adverse events were reported during the study period. Conclusion: SM-V, along with GG, is more effective in comparison with SM-R, thereby improving the quality of life of patients along with significant glycemic control and free from any untoward effect. Makaradhwaja can be used as an effective drug for diabetes.

Publisher

Medknow

Reference31 articles.

1. India – Diabetes capital of the world:Now heading towards hypertension;Joshi;J Assoc Physicians India,2007

2. Epidemiology of type 2 diabetes in India;Pradeepa;Indian J Ophthalmol,2021

3. The current state of diabetes mellitus in India;Kaveeshwar;Australas Med J,2014

4. Insulin therapy and hypoglycemia;McCall;Endocrinol Metab Clin North Am,2012

5. Update on safety issues related to antihyperglycemic therapy;Carpio;Diabetes Spectr,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3